Bevacizumab gamma for treating wet age-related macular degeneration

Evaluation committee members

This topic was considered by the lead team of the highly specialised technologies evaluation committee, which includes the chair and vice chair.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser and a project manager.

Aamer Jawed
Technical lead

Eleanor Donegan
Technical adviser

Louise Jafferally
Project manager

Ross Dent
Associate director

ISBN: 978-1-4731-6659-2